MIRA INFORM REPORT

 

 

 

Report Date :

29.07.2008

 

IDENTIFICATION DETAILS

 

Name :

SAFE PHARMA

 

 

Registered Office :

2nd Industrial Zone, Block 31, Area No. 3, New Borg El Arab, PO Box 49, Sidi Gaber, Alexandria

 

 

Country :

Egypt

 

 

Date of Incorporation :

1994

 

 

Legal Form :

Limited Liability Partnership

 

 

Line of Business :

Manufacture of Soft Gelatine Capsules for Vitamins

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 200,000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

 

 

 

 

 

SUMMARY

 

Company Name                         : SAFE PHARMA

Country of Origin                                    : Egypt

Legal Form                                            : Limited Liability Partnership

Registration Date                                   : 1994

Issued Capital                                        : £E 500,000

Paid up Capital                                      : £E 500,000

Total Workforce                         : 150

Activities                                               : Manufacture of soft gelatine capsules for vitamins

Financial Condition                                 : Undetermined

Payments                                             : Nothing detrimental uncovered

Recommended Credit Limit                     : US$ 200,000

 

 

 


 

 

COMPANY NAME

 

SAFE PHARMA

 

 

ADDRESS

 

Registered & Physical Address

 

Location            : 2nd Industrial Zone, Block 31, Area No. 3, New Borg El Arab

PO Box             : 49, Sidi Gaber

Town                 : Alexandria

Country : Egypt

Telephone         : (20-3) 4592158

Facsimile          : (20-3) 4592159

 

 

Premises

 

Subject operates from a large suite of offices and a factory that are owned and located in the Industrial Area of Alexandria.

 

 

KEY PRINCIPALS

 

     Name                                                                                               Position

 

·       Dr Hassan Abbass                                                                            Managing Partner

 

·       Dr Shreen Hassan Abbass                                                                 Partner

 

·       Yashar Hassan Abbass                                                                     Partner

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 1994

 

Legal Form                  : Limited Liability Partnership

 

Issued Capital              : £E 500,000

 

Paid up Capital            : £E 500,000

 

 
 
Name of Shareholder (s)

 

·       Dr Hassan Abbass

 

·       Dr Shreen Hassan Abbass

 

·       Yashar Hassan Abbass

 

 

OPERATIONS

 

Activities: Engaged in the manufacture of soft gelatine capsules for vitamins.

 

Import Countries: India, Germany and Austria

 

Subject has a workforce of approximately 150 employees.

 

 

FINANCIAL DATA

 

Companies registered in Egypt are not legally required to make their accounts public and no financial information was released by the company or submitted by outside sources.

 

 

BANKERS

 

·       National Societe Generale Bank

240 El Karnish Road

Rushdy

Alexandria

Tel: (20-3) 5452352 / 5225580 / 5225590

Fax: (20-3) 5455715 / 5452352

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk and the above credit figure is within subject’s financial means.

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.42.54

UK Pound

1

Rs.84.86

Euro

1

Rs.66.95

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions